These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37322260)

  • 21. Long non-coding RNA FLVCR1-AS1 functions as a ceRNA to aggravate cervical cancer cell growth by the miR-381-3p/MAGT1 axis.
    Zhang J; Yang X; Ni H
    Arch Gynecol Obstet; 2022 Dec; 306(6):2093-2103. PubMed ID: 35430713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
    Si Z; Yu L; Jing H; Wu L; Wang X
    J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA KIF9-AS1 promotes cell apoptosis by targeting the microRNA-148a-3p/suppressor of cytokine signaling axis in inflammatory bowel disease.
    Yao J; Gao R; Luo M; Li D; Guo L; Yu Z; Xiong F; Wei C; Wu B; Xu Z; Zhang D; Wang J; Wang L
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e922-e932. PubMed ID: 34750325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA PSMA3-AS1 functions as a competing endogenous RNA to promote gastric cancer progression by regulating the miR-329-3p/ALDOA axis.
    Kan L; Yang M; Zhang H
    Biol Direct; 2023 Jul; 18(1):36. PubMed ID: 37403106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p/S100A4 axis.
    Ren W; Ouyang L
    Environ Toxicol; 2024 Sep; 39(9):4447-4458. PubMed ID: 38953363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma.
    Dasgupta P; Kulkarni P; Majid S; Hashimoto Y; Shiina M; Shahryari V; Bhat NS; Tabatabai L; Yamamura S; Saini S; Tanaka Y; Dahiya R
    Cell Death Dis; 2020 Aug; 11(8):660. PubMed ID: 32814766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis.
    Han B; Ge Y; Cui J; Liu B
    Bioengineered; 2020 Dec; 11(1):524-535. PubMed ID: 32352854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
    Zhang ZB; Liu N
    Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo.
    Fu J; Zhang Y; Wang M; Hu J; Fang Y
    J Gene Med; 2021 Dec; 23(12):e3382. PubMed ID: 34350661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA PCED1B-AS1 mediates miR-3681-3p/MAP2K7 axis to promote metastasis, invasion and EMT in gastric cancer.
    Cao J; Yang Y; Duan B; Zhang H; Xu Q; Han J; Lu B
    Biol Direct; 2024 May; 19(1):34. PubMed ID: 38698487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis.
    Li H; Wang D; Yi B; Cai H; Wang Y; Lou X; Xi Z; Li Z
    Int J Biol Sci; 2021; 17(11):2912-2930. PubMed ID: 34345216
    [No Abstract]   [Full Text] [Related]  

  • 32. Up-Regulated LncRNA FEZF1-AS1 Promotes the Progression of Cervical Carcinoma Cells via MiR-367-3p/SLC12A5 Signal Axis.
    Yang X; Qu Y; Zhang J
    Arch Med Res; 2022 Jan; 53(1):9-19. PubMed ID: 34362591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression.
    Liu H; Zhang Q; Song Y; Hao Y; Cui Y; Zhang X; Zhang X; Qin Y; Zhu G; Wang F; Dang J; Ma S; Zhang Y; Guo W; Li S; Guan F; Fan T
    J Exp Clin Cancer Res; 2021 Sep; 40(1):287. PubMed ID: 34517880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA OSTM1-AS1 acts as an oncogenic factor in Wilms' tumor by regulating the miR-514a-3p/MELK axis.
    Du J; Xiao J; Zhuo Y; Nie M; Yang J; Luo X; Gu H
    Anticancer Drugs; 2022 Sep; 33(8):720-730. PubMed ID: 35946509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/PIM3 axis.
    Song W; Shi C
    Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G477-G488. PubMed ID: 34468207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00958 Targets miR-145-3p/CDK1 Axis to Aggravate the Malignancy of Colon Cancer.
    Zhou L; Mu D; Chen Y
    Ann Clin Lab Sci; 2022 Sep; 52(5):695-706. PubMed ID: 36261176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA SLCO4A1-AS1 modulates colon cancer stem cell properties by binding to miR-150-3p and positively regulating SLCO4A1.
    Wu K; Xu T; Song X; Shen J; Zheng S; Zhang L; Tao G; Jiang B
    Lab Invest; 2021 Jul; 101(7):908-920. PubMed ID: 33958701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
    Chen S; Li K
    BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.